Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

There is a lot of assumptions to calculate such es

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154836
(Total Views: 347)
Posted On: 04/02/2019 1:09:44 PM
Posted By: sjacobs26
Re: ClosetInvestor #1628
There is a lot of assumptions to calculate such especially before a licensing deal is inked as the royalty payments can vary significantly. But I'll attempt to provide some example calculations or you can look at Fine's evaluation model noted on ihub for another reference.

I'll stick to your $1B revenue number in the question instead of trying to guess another number with a lot of additional variables such as FDA approval time frame, market penetration, drug costs, etc. At this stage in the trial and FDA approval, IMO 18% is a conservative / reasonable / fair royalty rate for combo HIV (this varies by up-front/milestone payments, how far along in the trials the drug is, etc.).

1649290308_9.png

https://pharmaintelligence.informa.com/~/medi...report.pdf

We don't know the terms and revenue threshold limits, but they owe up to 10.5% to other companies (5% to Progenics, 3.5% to PDL/AbbVie, and 2% third-party licencor....see Note 8 & 9 in the Jan 9, 2019 10-Q).

670434399_10.png

https://ir.cytodyn.com/all-sec-filings/conten...005378.pdf

Based on 18% royalty deal, this leaves CYDY with 7.5% for their revenue (IMO the above percentages are conservative, so the final rates could be higher). 7.5% of $1B = $75M. Valuation on companies can be done multiple ways, but one of the most common is price to earnings ratio (P/E)......pre-revenue companies use price to sales (expected sales) and 4-1 is in the range for biotechs based on my previous research. Since we are talking revenue, I will use P/E of 15 (which is also conservative as this website has biotech P/E at 22.74 and historically has been much higher in the 30+ range).

https://csimarket.com/Industry/industry_valua...mp;ind=801

$75M revenue assuming 75% profit margin = $56.25M Earnings
assuming outstanding shares equals fully diluted shares or authorized shares of 600M
Earnings Per Share = ~$.094
multiply by 15 P/E = $1.41 Share Price

Market cap is determined by multiplying the current share price times the number of outstanding shares. So in this case $1.41 share price times 600M outstanding shares = $846M Market Cap.


(0)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Please do your own due diligence. All my posts and comments are not to be considered investment advice.




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us